Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination therapy, consisting of a corticosteroid and a local anesthetic, is being investigated by Wake Forest University Health Sciences for the treatment of chronic plantar fasciitis. The intervention is administered via a specialized percutaneous method known as the infracalcaneal peppering technique. This technique involves a single skin entry point through which the needle is redirected 20-25 times to fenestrate the pathologic plantar fascia while simultaneously depositing the medication. The corticosteroid component is intended to provide anti-inflammatory effects and long-term symptom relief, while the local anesthetic provides immediate analgesia and facilitates the mechanical peppering procedure. The therapy is currently being evaluated in a Phase 1 randomized clinical trial (NCT04443400) to compare the efficacy of the corticosteroid component against mechanical peppering with saline alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corticosteroid + local anesthetic.